Literature DB >> 16193294

Expression of protease-activated receptors and tissue factor in human liver.

Anne Rullier1, Nathalie Senant, Walter Kisiel, Paulette Bioulac-Sage, Charles Balabaud, Brigitte Le Bail, Jean Rosenbaum.   

Abstract

Thrombin, acting via protease-activated receptors (PARs), and tissue factor (TF) are involved in inflammation, tissue repair and tumorigenesis. Hepatocellular carcinomas (HCCs) usually complicate chronic liver diseases characterised by inflammation and fibrosis. The aim of this study was to describe the expression of PARs and TF in normal liver, cirrhosis and HCCs. We performed an immunohistochemical detection of PAR-1, PAR-3, PAR-4 and human TF in human tissue samples from 19 subnormal livers, 33 cirrhosis and 30 HCCs. PAR-1 was found on endothelial cells of sinusoids and larger vessels. In cirrhosis, spindle-shaped cells within septa and T lymphocytes were PAR-1 positive. A few PAR-1-positive tumour cells were found in 10% of HCCs. PAR-4 expression was restricted to macrophages, B lymphocytes and nerves. PAR-3 expression was rare. Unexpectedly, TF was expressed in 95% of normal livers and in 94% of cirrhosis but only in 50% of HCCs (p<0.001). Staining was mostly hepatocellular. No association existed between TF labelling and clinicopathological characteristics of HCCs. In conclusion, the pattern of expression of PARs is compatible with its role in chronic liver disease by promoting inflammation via immune cells and neurogenic stimulation. However, our data do not support a role for PARs or TF in HCC progression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16193294     DOI: 10.1007/s00428-005-0078-0

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  43 in total

1.  Tumor cell invasion is promoted by activation of protease activated receptor-1 in cooperation with the alpha vbeta 5 integrin.

Authors:  S C Even-Ram; M Maoz; E Pokroy; R Reich; B Z Katz; P Gutwein; P Altevogt; R Bar-Shavit
Journal:  J Biol Chem       Date:  2001-01-26       Impact factor: 5.157

2.  Cathepsin G activates protease-activated receptor-4 in human platelets.

Authors:  G R Sambrano; W Huang; T Faruqi; S Mahrus; C Craik; S R Coughlin
Journal:  J Biol Chem       Date:  2000-03-10       Impact factor: 5.157

Review 3.  Proteinase-activated receptors: novel signals for peripheral nerves.

Authors:  Nathalie Vergnolle; Mara Ferazzini; Michael R D'Andrea; Jörg Buddenkotte; Martin Steinhoff
Journal:  Trends Neurosci       Date:  2003-09       Impact factor: 13.837

4.  Expression of the thrombin receptor in human liver: up-regulation during acute and chronic injury.

Authors:  F Marra; R DeFranco; C Grappone; S Milani; M Pinzani; G Pellegrini; G Laffi; P Gentilini
Journal:  Hepatology       Date:  1998-02       Impact factor: 17.425

5.  Role of protease-activated receptor 1 in tumor metastasis promoted by tissue factor.

Authors:  M E Bromberg; M A Bailly; W H Konigsberg
Journal:  Thromb Haemost       Date:  2001-11       Impact factor: 5.249

Review 6.  Tissue factor-factor VIIa signaling.

Authors:  L Vijaya Mohan Rao; Usha R Pendurthi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-11-29       Impact factor: 8.311

7.  PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells.

Authors:  Adrienne Boire; Lidija Covic; Anika Agarwal; Suzanne Jacques; Sheida Sherifi; Athan Kuliopulos
Journal:  Cell       Date:  2005-02-11       Impact factor: 41.582

8.  Regulation of protease-activated receptor-1 in mononuclear cells by neutrophil proteases.

Authors:  N Roche; R G Stirling; S Lim; B G Oliver; K F Chung
Journal:  Respir Med       Date:  2003-03       Impact factor: 3.415

9.  Tumoral angiogenesis and tissue factor expression during hepatocellular carcinoma progression in a transgenic mouse model.

Authors:  Evelyne Dupuy; Patricia Hainaud; Aude Villemain; Eva Bodevin-Phèdre; Jean Philippe Brouland; Pascale Briand; Gérard Tobelem
Journal:  J Hepatol       Date:  2003-06       Impact factor: 25.083

10.  Chemotactic response of monocytes to thrombin.

Authors:  R Bar-Shavit; A Kahn; J W Fenton; G D Wilner
Journal:  J Cell Biol       Date:  1983-01       Impact factor: 10.539

View more
  15 in total

1.  Role of fibrinogen and protease-activated receptors in acute xenobiotic-induced cholestatic liver injury.

Authors:  James P Luyendyk; Nigel Mackman; Bradley P Sullivan
Journal:  Toxicol Sci       Date:  2010-10-25       Impact factor: 4.849

Review 2.  Expression of proteinase-activated receptor 1-4 (PAR 1-4) in human cancer.

Authors:  Andrea Pia Elste; Iver Petersen
Journal:  J Mol Histol       Date:  2010-06-20       Impact factor: 2.611

3.  Protease-activated receptor 1 and hematopoietic cell tissue factor are required for hepatic steatosis in mice fed a Western diet.

Authors:  Karen M Kassel; A Phillip Owens; Cheryl E Rockwell; Bradley P Sullivan; Ruipeng Wang; Ossama Tawfik; Guodong Li; Grace L Guo; Nigel Mackman; James P Luyendyk
Journal:  Am J Pathol       Date:  2011-09-09       Impact factor: 4.307

4.  Protease-activated receptor 4 protects mice from Coxsackievirus B3 and H1N1 influenza A virus infection.

Authors:  Kohei Tatsumi; Clare M Schmedes; E Reaves Houston; Emily Butler; Nigel Mackman; Silvio Antoniak
Journal:  Cell Immunol       Date:  2019-07-03       Impact factor: 4.868

5.  Protease-activated receptor 4 plays a role in lipopolysaccharide-induced inflammatory mechanisms in murine macrophages.

Authors:  A Barra; K M Freitas; D G Marconato; P Faria-Pinto; M T P Lopes; André Klein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-11-07       Impact factor: 3.000

6.  Clinical Significance of Serum Antithrombin III Activity After Hepatectomy for Hepatocellular Carcinoma.

Authors:  Naruo Tokuyasu; Masataka Amisaki; Takehiko Hanaki; Yuki Murakami; Masaki Morimoto; Ei Uchinaka; Takuki Yagyu; Keisuke Goto; Tomoyuki Matsunaga; Manabu Yamamoto; Shuichi Takano; Teruhisa Sakamoto; Soichiro Honjo; Toshimichi Hasegawa; Yoshiyuki Fujiwara
Journal:  Yonago Acta Med       Date:  2021-04-15       Impact factor: 1.641

7.  Proteinase-activated receptor-1 and immunomodulatory effects of a PAR1-activating peptide in a mouse model of prostatitis.

Authors:  M Mark Stanton; Lisa K Nelson; Hallgrimur Benediktsson; Morley D Hollenberg; Andre G Buret; Howard Ceri
Journal:  Mediators Inflamm       Date:  2013-12-29       Impact factor: 4.711

8.  Factor VII promotes hepatocellular carcinoma progression through ERK-TSC signaling.

Authors:  M-C Tsai; K-D Chen; C-C Wang; K-T Huang; C-H Wu; I-Y Kuo; L-Y Chen; T-H Hu; S Goto; T Nakano; A Dorling; J H McVey; C-L Chen; C-C Lin
Journal:  Cell Death Discov       Date:  2015-11-30

9.  Proteinase activated receptor 1 mediated fibrosis in a mouse model of liver injury: a role for bone marrow derived macrophages.

Authors:  Yiannis N Kallis; Christopher J Scotton; Alison C Mackinnon; Robert D Goldin; Nicholas A Wright; John P Iredale; Rachel C Chambers; Stuart J Forbes
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

Review 10.  The coagulation factor Xa/protease activated receptor-2 axis in the progression of liver fibrosis: a multifaceted paradigm.

Authors:  Keren Borensztajn; Jan H von der Thüsen; Maikel P Peppelenbosch; C Arnold Spek
Journal:  J Cell Mol Med       Date:  2009-11-28       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.